World Journal of Gastroenterology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Gu B, Venkatesh K, Williams AJ, Ng W, Corte C, Gholamrezaei A, Ghaly S, Xuan W, Paramsothy S, Connor S. Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn’s disease. World J Gastroenterol 2022; 28(23): 2597-2608 [PMID: 35949350 DOI: 10.3748/wjg.v28.i23.2597]
URL:	https://www.wjgnet.com/1007-9327/full/v28/i23/2597.htm

(200) (207) (0) (0) (0) (19) (7734) (32)

Number	Citing Articles
1	Alyssa M. Parian, Megan Obi, Phillip Fleshner, David A. Schwartz. Management of Perianal Crohn's Disease. American Journal of Gastroenterology 2023; 118(8) doi: 10.14309/ajg.0000000000002326
2	Eathar Shakweh, Luke Hanna, Easan Anand, Theo Pelly, Shivani Joshi, Sulak Anandabaskaran, James Alexander, Nick Powell, Janindra Warusavitarne, Phil Tozer, Ailsa Hart. Getting to the bottom of it: essential insights into perianal Crohn’s disease. Frontline Gastroenterology 2026; doi: 10.1136/flgastro-2024-103014
3	Luke N. Hanna, Sulak Anandabaskaran, Nusrat Iqbal, Jeroen Geldof, Jean-Frédéric LeBlanc, Anders Dige, Lilli Lundby, Séverine Vermeire, André D’Hoore, Bram Verstockt, Gabriele Bislenghi, Danny De Looze, Triana Lobaton, Dirk Van de Putte, Antonino Spinelli, Michele Carvello, Silvio Danese, Christianne J. Buskens, Krisztina Gecse, Roel Hompes, Marte Becker, Jarmila van der Bilt, Willem Bemelman, Shaji Sebastian, Gordan Moran, Amy L. Lightner, Serre-Yu Wong, Jean-Frédéric Colombel, Benjamin L. Cohen, Stefan D. Holubar, Nik S. Ding, Corina Behrenbruch, Kapil Sahnan, Ravi Misra, Phillip Lung, Ailsa Hart, Phil Tozer. Perianal Fistulizing Crohn’s Disease: Utilizing the TOpClass Classification in Clinical Practice to Provide Targeted Individualized Care. Clinical Gastroenterology and Hepatology 2025; 23(6) doi: 10.1016/j.cgh.2024.06.047
4	Dror S Shouval, Iva Hojsak, Erasmo Miele, Christiane Sokollik, Dan Turner, Kaija-Leena Kolho, Rotem Sigall-Boneh, Patrick F van Rheenen, Eytan Wine, Richard K Russell, Seamus Hussey, Neil Chanchlani, Amit Assa, Javier Martin de Carpi, Luca Scarallo, Anne M Griffiths, Anat Yerushalmy-Feler, Caterina Strisciuglio, Lissy de Ridder, Jiri Bronsky, Hannah Gordon, Michel Adamina, Johanna C Escher, Marco Gasparetto, Laura Gianolio, David C Wilson, Marina Aloi. Management of pediatric Crohn’s disease: an ECCO-ESPGHAN guideline update. Journal of Crohn’s and Colitis 2026; 20(8) doi: 10.1093/ecco-jcc/jjag084
5	Tatiana Gabrusskaya, Natalia Ulanova, Elena Shilova, Natalia Volkova, Sofia Kilina, Elena Kornienko, Mikhail Kostik. Efficacy and safety of dual-targeted therapy in children with inflammatory bowel disease: Retrospective cohort study. World Journal of Clinical Pediatrics 2026; 15(1): 111093 doi: 10.5409/wjcp.v15.i1.111093 Abstract(137) \| Core Tip(88) \| Full Article(HTML)(407) \| Full Article (PDF)-559K(171) \| Full Article with Cover (PDF)-992K(22) \| Full Article (XML)-118K(24) \| Audio-1103K(7) \| Peer-Review Report-232K(29) \| Answering Reviewers-90K(38) \| Times Cited (0) \| Total Visits (813) \| Open
6	Sulak Anandabaskaran, Zhigang Liu, Luke Hanna, Phillip Lung, James L. Alexander, Nick Powell, Susan J. Connor, Phil Tozer, Ailsa Hart. Tissue penetration of anti-tumour necrosis factor therapy in perianal fistulising Crohn’s disease: a proof-of-concept study. European Journal of Gastroenterology & Hepatology 2026; 38(8) doi: 10.1097/MEG.0000000000003169
7	Xiaoxia Deng, Zicheng Huang, Qiuyue Xia, Zhaopeng Huang, Yue Wu, Yanhui Wu, Qing Li, Na Diao, Miao Li, Jian Tang, Qin Guo, Xiang Gao, Qing fan Yang, Kang Chao. Exclusive enteral nutrition improves radiological outcomes in adults with perianal fistulizing Crohn's disease: A real‐world retrospective cohort study. Nutrition in Clinical Practice 2026; 41(4) doi: 10.1002/ncp.70135
8	Pauline Wils, Stéphane Nancey, Elodie Messmer, Arnaud Bourreille, Anthony Buisson, Ludovic Caillo, Lucine Vuitton, Romain Altwegg, Xavier Hébuterne, Olivier Ernst, Paul Meunier, Valerie Laurent, Stephane Paul, David Laharie, Eric Vicaut, Laurent Peyrin-Biroulet. Ustekinumab for fistulising perianal Crohn’s disease: a randomised placebo-controlled trial from the GETAID. Gut 2026; doi: 10.1136/gutjnl-2026-339158
9	Jiayin Yao, Heng Zhang, Tao Su, Xiang Peng, Junzhang Zhao, Tao Liu, Wei Wang, Pinjin Hu, Min Zhi, Min Zhang. Ustekinumab Promotes Radiological Fistula Healing in Perianal Fistulizing Crohn’s Disease: A Retrospective Real-World Analysis. Journal of Clinical Medicine 2023; 12(3) doi: 10.3390/jcm12030939
10	Saher‐Zahra Khan, Andrea Arline, Kate M. Williams, Matthew J. Lee, Emily Steinhagen, Sharon L. Stein. The use of core descriptors from the ENiGMA code study in recent literature: a systematic review. Colorectal Disease 2024; 26(3) doi: 10.1111/codi.16893
11	WonKyung J. Cho, Serre-Yu Wong. A Guide Through the Tunnel: Updates in the Approach to Classification and Management of Perianal Fistulizing Crohn’s Disease. Current Gastroenterology Reports 2025; 27(1) doi: 10.1007/s11894-025-00998-0
12	Laura Maas, Ruiyi Gao, Vivy Cusumano, Ellen Spartz, Reezwana Chowdhury, Mahesh Krishna, Mark Lazarev, Joanna Melia, Florin Selaru, Sowmya Sharma, Berkeley Limketkai, Alyssa Parian. Superior Efficacy of Infliximab Versus Adalimumab for First-Line Treatment of Crohn’s Perianal Fistulae. Digestive Diseases and Sciences 2023; 68(10) doi: 10.1007/s10620-023-08060-7
13	Lina M. Felipez, Sabina Ali, Edwin F. de Zoeten, Anne M. Griffiths, Sandra C. Kim, Ashish S. Patel, Joel R. Rosh, Jeremy Adler. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition position paper on the therapeutic drug monitoring in pediatric inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition 2025; 81(4) doi: 10.1002/jpn3.70158
14	Emerging Therapeutic Targets and Drug Delivery Approaches in IBD. Advances in Pharmacology 2024; 101 doi: 10.1016/bs.apha.2024.10.013
15	Elise M. Meima - van Praag, Marte A.J. Becker, Kyra L. van Rijn, Karin A.T.G.M. Wasmann, Jaap Stoker, Geert R.A.M. D'Haens, Cyriel Y. Ponsioen, Krisztina B. Gecse, Marcel G.W. Dijkgraaf, Antonino Spinelli, Silvio Danese, Willem A. Bemelman, Christianne J. Buskens. Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy alone for Crohn's perianal fistulas (PISA-II): long-term outcomes of an international, multicentre patient preference, randomised controlled trial. eClinicalMedicine 2023; 61 doi: 10.1016/j.eclinm.2023.102045
16	Mengqi Chen, Zihan Chen, Jianming Lin, Linxin Liu, Tong Tu, Xiaoling Li, Baili Chen, Yao He, Minhu Chen, Zhirong Zeng, Xiaojun Zhuang. Comparative effectiveness of ustekinumab versus infliximab in the management of perianal fistulizing Crohn's disease: a retrospective study in China. Intestinal Research 2026; 24(1) doi: 10.5217/ir.2024.00168
17	Dongxing Cao, Keyu Qian, Ying Zhao, Jie Hong, Haoyan Chen, Xiaohui Wang, Nailin Yang, Cheng Zhang, Jingkai Cao, Keyu Jia, Guangyu Wu, Mingming Zhu, Jun Shen, Ye Zhang, Zhe Cui, Zheng Wang. Association of Neutrophil Extracellular Traps with Fistula Healing in Patients with Complex Perianal Fistulizing Crohn’s Disease. Journal of Crohn's and Colitis 2023; 17(4) doi: 10.1093/ecco-jcc/jjac171
18	Tarek Aboursheid, Azizullah Beran, Mohamad Hijazi, Mhd Kutaiba Albuni, Bisher Sawaf, John J. Guardiola, Khaled Abdeljawad, Benjamin D. McDonald, David T. Rubin. Comparison Between Adalimumab and Infliximab in Perianal Crohn’s Disease: A Systematic Review and Meta-Analysis. Gastro Hep Advances 2025; 4(8) doi: 10.1016/j.gastha.2025.100697
19	E. F. Miranda, R. B. Nones, F. B. Baraúna, G. de Nardi Marçal, M. Olandoski, T. P. de Moraes, P. G. Kotze. Infliximab serum concentrations and disease activity in perianal fistulizing Crohn’s disease: a cross-sectional study. Techniques in Coloproctology 2024; 28(1) doi: 10.1007/s10151-024-02953-z
20	Gary R. Lichtenstein, Edward V. Loftus, Anita Afzali, Millie D. Long, Edward L. Barnes, Kim L. Isaacs, Christina Y. Ha. ACG Clinical Guideline: Management of Crohn's Disease in Adults. American Journal of Gastroenterology 2025; 120(6) doi: 10.14309/ajg.0000000000003465
21	Mahesh Krishna, Ellen J. Spartz, Laura Maas, Vivy Cusumano, Sowmya Sharma, Berkeley Limketkai, Alyssa Parian. Retrospective Cohort Study on the Predictive Value of Primary Non-response to Initial Biologic for Future Biologic Use in Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences 2025; 70(2) doi: 10.1007/s10620-024-08816-9
22	Axel Dignass, Catherine Reenaers, Anthony Buisson, Fernando Magro, Lucine Vuitton, Soyeon Park, Meoung Jun Park, Bruce E. Sands. Subcutaneous infliximab in the treatment of patients with perianal fistulizing Crohn’s disease: current evidence and emerging roles. Therapeutic Advances in Gastroenterology 2026; 19 doi: 10.1177/17562848261461042
23	Hajime Kayano, Ken-Ichi Okada, Seiichiro Yamamoto, Kazuo Koyanagi. Establishment of a surveillance program for anal cancer in Crohn's disease. World Journal of Gastroenterology 2024; 30(45): 4844-4849 doi: 10.3748/wjg.v30.i45.4844 Abstract(575) \| Core Tip(636) \| Full Article(HTML)(1893) \| Full Article (PDF)-1236K(199) \| Full Article with Cover (PDF)-2618K(190) \| Full Article (XML)-95K(126) \| Audio-255K(18) \| Peer-Review Report-174K(119) \| Answering Reviewers-203K(127) \| Times Cited (1) \| Total Visits (2979) \| Open
24	Konstantinos Papamichael, Andrea Centritto, Lucas Guillo, Jessica Hier, Zachary Sherman, Adam S. Cheifetz, Dorsaf Zoghlami, Sivan Harnik, Lieven Mulders, Nikolaos Kamperidis, Sylvia Sidky, Alexandra Bruss, Tina Deyhim, Mark A. Samaan, Andres J. Yarur, Byron P. Vaughn, Naila Arebi, Krisztina B. Gecse, Bella Ungar, Xavier Roblin, Stephane Paul, Robert Battat, Waqqas Afif, Laurent Peyrin-Biroulet, Peter M. Irving. Higher Adalimumab Concentration Is Associated With Complete Fistula Healing in Patients With Perianal Fistulizing Crohn’s Disease. Clinical Gastroenterology and Hepatology 2024; 22(10) doi: 10.1016/j.cgh.2024.04.005
25	Tatiana Pacheco, Sara Monteiro, Luísa Barros, Jorge Silva. Perianal disease in inflammatory bowel disease: Broadening treatment and surveillance strategies for anal cancer. World Journal of Gastroenterology 2024; 30(28): 3373-3385 doi: 10.3748/wjg.v30.i28.3373 Abstract(773) \| Core Tip(873) \| Full Article(HTML)(5198) \| Full Article (PDF)-4599K(300) \| Full Article with Cover (PDF)-4941K(252) \| Full Article (XML)-227K(147) \| Audio-883K(19) \| Peer-Review Report-218K(165) \| Answering Reviewers-105K(147) \| Times Cited (6) \| Total Visits (6394) \| Open
26	Joonhyuk Son, Sungjoo Park, Seon Young Kim, Yoon Zi Kim, Hansol Kim, Wontae Kim, Sanghoon Lee, Jeong-Meen Seo, Yon Ho Choe, Mi Jin Kim. Higher induction and maintenance infliximab trough levels are associated with radiological perianal fistula healing in pediatric patients with Crohn's disease. Frontiers in Pediatrics 2025; 13 doi: 10.3389/fped.2025.1565344
27	Habeeb Habeeb, Lynna Chen, Isabelle De Kock, Gauraang Bhatnagar, Numan Kutaiba, Abhinav Vasudevan, Ashish R Srinivasan. Imaging in perianal fistulising Crohn’s disease: A practical guide for the gastroenterologist. World Journal of Gastroenterology 2025; 31(34): 110611 doi: 10.3748/wjg.v31.i34.110611 Abstract(288) \| Core Tip(255) \| Full Article(HTML)(1623) \| Full Article (PDF)-4018K(319) \| Full Article with Cover (PDF)-4333K(102) \| Full Article (XML)-253K(67) \| Audio-162K(26) \| Peer-Review Report-264K(66) \| Answering Reviewers-89K(63) \| Times Cited (9) \| Total Visits (2585) \| Open
28	Davide Giuseppe Ribaldone, Giulia Valdiserra, Clelia Di Salvo, Ilaria Puxeddu, Lorenzo Bertani, Luca Antonioli. The right drug at the right time: key to IBD success. Trends in Molecular Medicine 2026; 32(7) doi: 10.1016/j.molmed.2025.10.010
29	Xiaoyu Liu, Yuehua Yan, Jiaqin Yi, Dongmei Luo, Jun Geng, Huixian Huang, Jingjing Wang, Yunfei Gu, Bolin Yang, Yuxia Gong, Hao Wang. Ustekinumab trough concentrations predict clinical remission in perianal fistulizing crohn’s disease: a real-world retrospective cohort study. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-04323-x
30	Peeyush Kumar, Arshdeep Singh, Neha Berry, Vandana Midha, Rupa Banerjee, Naresh Bhat, Adarsh Chaudhary, Devendra Desai, Usha Dutta, Pankaj Garg, Uday C. Ghoshal, Chandan Kakkar, Saurabh Kedia, Govind Makharia, Sandeep Nijhawan, Partha Pal, Mathew Philip, Amarender Puri, G. V. Rao, Vishal Sharma, Satpal Singh Virk, Rakesh Kochhar, Ajit Sood, Ajay Kumar, Vineet Ahuja. Perianal fistulizing Crohn’s disease: Clinical practice update from Colitis and Crohn’s Foundation (India). Indian Journal of Gastroenterology 2026; 45(3) doi: 10.1007/s12664-025-01880-7
31	Joseph Lee, Amy Lightner. Management and Treatment of Perianal Fistulizing Crohn’s Disease. Clinical and Experimental Gastroenterology 2025; doi: 10.2147/CEG.S528149
32	Jana G Hashash, Jimmy K Limdi, Jason M Shapiro, Samir A Shah. Medical management of inflammatory bowel diseases. BMJ 2025; 391 doi: 10.1136/bmj-2025-079050